Total Funding
74
Total FundingGrant raised
Growth Score in past quarter
pts
Heat Score 74 in past quarter
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
ConquerX is a biotechnology company that provides innovative molecular profiling solutions to clinical trials in precision medicine.
Deborah Zanforlin: CEO & Co-founder
About the Company
ConquerX is a biotechnology company that provides innovative molecular profiling solutions to clinical trials in precision medicine.
The company's flagship product, the EbeGen, is an electro-chemical biosensor capable of detecting multiple molecular targets such as DNAs, RNAs, mirRNAs at the same time, without the need for sequencing and qPCR
and at 10-time more cost effective compared to current technologies.
Women Founded
Women Led